Taxotere's Ambiguous Hair Loss Warning

Sanofi-Aventis is using semantics and word games rather than clarity to warn cancers that their hair could fall out permanently from using their drug called Taxotere

Monday, February 5, 2018 - For people suffering from the side effects of anti-cancer chemotherapy drug Taxotere, company warnings are proving to be inadequate. No matter how hard one tries to stay positive most cancer patients expect to suffer adverse side effects from chemotherapy including temporary hair loss. Most cancer patients accept the fact that chemotherapy may not even be successful and that they may die from the disease.

Fear of the unknown overwhelms a person when they first find out they have cancer. Many questions immediately come to mind such as who will raise their children if they die and how long do they have to live. Given the consequences of their death on their family, most cancer patients are willing to suffer adverse chemo side effects such as nausea, loss of appetite, weight loss, headaches, lesions that do not heal, lethargy, diarrhea, infections, mouth sores, and liver toxicity problems and many others including temporary hair loss. Normally it is not even an option to consider rejecting chemotherapy and trying to go it alone as doing so is likened by their doctor to a death sentence.

Cancer patients will do almost anything to have a chance of one day having their lives return to normal. Side effects are to be expected and allergic reactions to chemotherapy include hives, rashes, breathing difficulty, lightheadedness, facial swelling, swollen tongue and difficulty swallowing. Cancer patients are experiencing permanent baldness, not the temporary baldness that they were warned to expect as Taxotere has proven to be so toxic that it causes permanent, irreversible baldness in 10-15% of patients that take the drug.

Lawsuits against Sanofi-Aventis allege that the company was aware of the fact that Taxotere caused permanent Alopecia as early as 2005 and did little to warn consumers. Instead of making a clear and understandable statement regarding Taxotere's causing permanent hair loss, the company chose to play down the seriousness of the side effect by stating,

"hair loss: in most cases, normal hair growth should return. In some cases (frequency not known) permanent hair loss has been observed."

Taxotere permanent hair loss plaintiffs claim that if they had been aware that there was a 10-15% chance that their hair loss would be permanent, they would not have accepted chemotherapy or at a minimum asked their doctor to recommend a chemotherapy drug that was less toxic. Taxotere's toxicity is so high that it need be administered only half as often as other chemotherapy drugs. In addition to failing to warn consumers, Sanofi is also being sued based on the unfair and deceptive sales practices of their drug marketing representatives. While there is no disputing that Taxotere is effective in fighting cancer, there is no evidence to support that it is more effective than Taxol, the drug it was marketed to replace.

Taxotere lawsuits seek to compensate plaintiffs for medical expenses, lost wages, and the ongoing pain and suffering due to the psychological trauma resulting from having to live the rest of their lives without hair.

More Recent Taxotere Hair Loss Lawsuit News:

• Taxotere Alopecia Warning Limited to the Fine Print | 5/17/2019
• Women that have to undergo chemotherapy for the first time face great anxiety | 5/6/2019
• Taxotere Patients Denied Their Right To Make An Informed Decision | 4/24/2019
• Patients Must Be Made Aware Of Taxotere's Three Major Side Effects | 4/18/2019
• Women Are Angry Over Sanofi Failing To Warn About The Possibility of Permanent Hair Loss | 4/12/2019
• Women Undergoing Cancer Treatments Are Taking Better Care of Themselves to Limit Hair Loss | 4/5/2019
• Taxotere Permanent Hair Loss Has Devastating Psychological Implications For Patients | 3/25/2019
• Taxotere Causes Alopecia Which Can Be Psychologically Damaging | 3/20/2019
• Drug Makers Need To Write Clearer, More Descriptive Drug Warnings Starting With Taxotere | 3/18/2019
• Taxotere Lawsuits May Teach Doctors a Valuable Lesson | 3/13/2019
• Taxotere Permanent Baldness Warning | 4/30/2018
• Taxotere Chemotherapy and Permanent Hair Loss | 4/26/2018
• Sanofi Sales Representatives Oversold Taxotere | 4/24/2018
• Scientific Study Confirms Permanent Taxotere Hair Loss | 4/12/2018
• Chemotherapy Drug Side Effects | 4/9/2018
• Cancer Doctors Fail to Warn Patients | 4/4/2018
• Taxotere's Psychological Side Effects | 3/13/2018
• Permanent Hair Loss Can Lead to Depression | 3/6/2018
• A Woman's Hair is Linked to Their Feminity | 2/23/2018
• Studies Indicate Taxotere Causes Permanent Hair Loss | 2/14/2018
• Permanent Hair Loss Makes the Fear of Growing Old All Too Real | 12/29/2017
• Thousands of Women File Taxotere Hair Loss Lawsuits | 12/27/2017
• Taxotere Patients Psychological Trauma Result in Lawsuits Against Sanofi-Aventis | 12/22/2017
• Scientific Studies Point to Taxotere Hair Loss | 12/18/2017
• Cancer Patients Right to Make an Informed Decision | 12/13/2017
• How Women Think About Chemotherapy Hair Loss | 12/11/2017
• The Emotional Side Effects of Alopecia | 12/8/2017
• Taxotere May Cause Permanent Hair Loss | 12/4/2017
• Women Equate Baldness With Masculinity | 11/27/2017
• Symptoms of Permanent Hair Loss | 11/21/2017
• Taxotere's Warning May Have Come Too Late For Many | 11/15/2017
• Taxotere Benefits and Side Effects | 11/9/2017
• Women Were Not Given a Choice of Cancer Drugs | 11/1/2017
• The Impact of Permanent Hair Loss on Some Cancer Survivors | 9/29/2017
• The Emotional Side Effects of Permanent Hair Loss For Women Are All Too Real | 9/22/2017
• Taxotere is Highly Toxic and Causes Permanent Hair Loss | 9/15/2017
• 10-15 Percent of Cancer Patients Given Taxotere Develop Permanent Hair Loss | 9/8/2017
• Permanent Hair Loss From Taxotere is a Real Possibility | 9/1/2017
• Taxotere Permanent Hair Loss Lawsuits | 7/21/2017
• Permanent Hair Loss Caused by Taxotere | 6/26/2017
• Taxotere Warnings Now Include Permanent Hair Loss | 6/19/2017
• Taxotere Hair Loss Lawsuits Focus on Warning Label | 6/12/2017
• Permanent Hair Loss in Some Taxotere Users Delivers Secondary Blow to Cancer Patients | 6/5/2017

Lawyers for Taxotere Hair Loss Lawsuits

Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.